マイクロバイオームシーケンスサービス市場：動向、機会、競合分析【2023-2028年】

マイクロバイオームシーケンスサービス市場の動向と予測

マイクロバイオームシーケンスサービスの世界市場は、2023年から2028年までのCAGRが12.4%で、2028年までに推定24億米ドルに達すると予測されます。この市場の主な促進要因は、メタゲノム解析技術に対する需要の高まり、ヒトマイクロバイオーム治療薬の市場開拓への高い集中力、および高度なシーケンス機器に関連する高コストです。世界のマイクロバイオームシーケンスサービス市場の将来は、製薬企業やバイオテクノロジー企業、学術研究機関におけるビジネスチャンスによって有望視されています。

マイクロバイオームシーケンスサービス市場の洞察

• Lucintelは、数百万個のアンプリコンの同時シーケンスが可能な並列性の高い構造であること、また、腸、皮膚、その他の臓器（それぞれ明確な微生物指紋を持つ）の細菌集団の研究に対する関心が高まっていることから、合成によるシーケンシング（SBS）が予測期間中最も高い成長セグメントであり続けると予測しています。さらに、いくつかの営利企業によって広く利用されている手法でもあります。
• この市場の中では、研究および学術分野でのタンパク質や低分子の検査にマイクロバイオームシーケンスサービスが広く利用されていることから、学術・研究機関が最大のエンドユース産業セグメントであり続けると思われます。
• 北米は、よく整備された研究枠組み、最先端の技術開発、およびこの地域における精密医薬品のニーズの高まりにより、予測期間中も最大の地域であり続けると思われます。

本レポートでは、以下の11の主要な質問に回答している：

• Q.1.市場セグメントのうち、最も有望かつ高成長な機会は何か？
• Q.2.どのセグメントがより速いペースで成長するのか、またその理由は？
• Q.3.今後成長が加速すると思われる地域とその理由は？
• Q.4.市場力学に影響を与える主な要因は何か？市場における主な課題とビジネスリスクは？
• Q.5.この市場におけるビジネスリスクと競合の脅威は？
• Q.6.この市場における新たな動向とその理由は？
• Q.7.市場における顧客の需要の変化にはどのようなものがありますか？
• Q.8.この市場における新たな開発と、その開発をリードしている企業は？
• Q.9.この市場における主要企業は？主要企業は事業成長のためにどのような戦略的取り組みを進めているのか？
• Q.10.この市場における競合製品にはどのようなものがあり、材料や製品の代替による市場シェア低下の脅威はどの程度ありますか？
• Q.11.過去5年間にどのようなM&Aが行われ、業界にどのような影響を与えましたか？

目次

第1章 エグゼクティブサマリー

第2章 世界のマイクロバイオームシーケンスサービス市場：市場力学

• イントロダクション、背景、分類
• サプライチェーン
• 業界の促進要因と課題

第3章 2017年から2028年までの市場動向と予測分析

• マクロ経済動向（2017～2022年）と予測（2023～2028年）
• 世界のマイクロバイオームシーケンスサービス市場動向（2017-2022）および予測（2023-2028）
• テクノロジー別の世界のマイクロバイオームシーケンスサービス市場
  • 合成による配列決定（SBS）
  • ライゲーションによるシーケンス（SBL）
  • ナノポアシーケンシング
  • サンガー配列決定
  • その他
• タイプ別の世界のマイクロバイオームシーケンスサービス市場
  • アンプリコンの配列決定
  • 全ゲノム配列決定
  • ショットガンのシーケンス
  • その他
• 最終用途産業別の世界のマイクロバイオームシーケンスサービス市場
  • 製薬会社およびバイオテクノロジー会社
  • 学術調査機関
  • その他

第4章 2017年から2028年までの地域別の市場動向と予測分析

• 地域別の世界のマイクロバイオームシーケンスサービス市場
• 北米のマイクロバイオームシーケンスサービス市場
• 欧州のマイクロバイオームシーケンスサービス市場
• 欧州のマイクロバイオームシーケンスサービス市場
• アジア太平洋マイクロバイオームシーケンスサービス市場
• その他地域マイクロバイオームシーケンスサービス市場

第5章 競合の分析

• 製品ポートフォリオ分析
• 運用上の統合
• ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

• 成長機会分析
  • 技術別の世界のマイクロバイオームシーケンスサービス市場の成長機会
  • タイプ別の世界のマイクロバイオームシーケンスサービス市場の成長機会
  • 最終用途産業別の世界のマイクロバイオームシーケンスサービス市場の成長機会
  • 地域別の世界のマイクロバイオームシーケンスサービス市場の成長機会
• 世界のマイクロバイオームシーケンスサービス市場の新たな動向
• 戦略的分析
  • 新製品の開発
  • 世界のマイクロバイオームシーケンスサービス市場の能力拡大
  • 世界のマイクロバイオームシーケンスサービス市場における合併、買収、合弁事業
  • 認証とライセンシング

第7章 有力企業の企業プロファイル

• Microbiome Insights
• Baseclear
• Clinical-Microbiomics
• Merieux NutriSciences Corporation
• MR DNA
• Metabiomics
• Rancho BioSciences
• Second Genome
• Zymo Research Corporation
• uBiome

Microbiome Sequencing Service Market Trends and Forecast

The future of the global microbiome sequencing service market looks promising with opportunities in pharmaceutical and biotechnology companies and academic and research institutes. The global microbiome sequencing service market is expected to reach an estimated $2.4 billion by 2028 with a CAGR of 12.4% from 2023 to 2028. The major drivers for this market are increasing demand for metagenomic sequencing technology, high concentration on development of human microbiome therapeutics, as well as high costs associated with sophisticated sequencing instruments.

A more than 150-page report is developed to help in your business decisions.

Microbiome Sequencing Service Market by Segment

The study includes trends and forecast for the global microbiome sequencing service market by technology, type, and end use industry, and region.

Microbiome Sequencing Service Market by Technology [Shipment Analysis by Value from 2017 to 2028]:

• Sequencing by Synthesis (SBS)
• Sequencing by Ligation (SBL)
• Nanopore Sequencing
• Sanger Sequencing
• Others

Microbiome Sequencing Service Market by Type [Shipment Analysis by Value from 2017 to 2028]:

• Amplicon Sequencing
• Whole-Genome Sequencing
• Shotgun Sequencing
• Others

Microbiome Sequencing Service Market by End Use Industry [Shipment Analysis by Value from 2017 to 2028]:

• Pharmaceutical and Biotechnology Companies
• Academic and Research Institutes
• Others

List of Microbiome Sequencing Service Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies, microbiome sequencing service companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the microbiome sequencing service companies profiled in this report include:

• Microbiome Insights
• Baseclear
• Clinical-Microbiomics
• Merieux NutriSciences Corporation
• MR DNA
• Metabiomics
• Rancho BioSciences
• Second Genome
• Zymo Research Corporation
• uBiome

Microbiome Sequencing Service Market Insights

• Lucintel forecasts that sequencing by synthesis (SBS) will remain the highest growing segment over the forecast period due to its highly parallel structure that enables the simultaneous sequencing of millions of amplicons and increased interest in studying bacterial populations in the gut, skin, and other organs, each of which has a distinct microbial fingerprint. Moreover, it is an extensively used method by several commercial companies.
• Within this market, academic and research institutes will remain the largest end use industry segment due to extensive utilization of microbiome sequencing services for the examination of proteins and small molecules within the research and academic sectors.
• North America will remain the largest region over the forecast period due to well-developed research framework, cutting-edge technological progress, and the growing need for precision medicines in this region.

Features of the Global Microbiome Sequencing Service Market

• Market Size Estimates: Microbiome sequencing service market size estimation in terms of value ($B).
• Trend and Forecast Analysis: Market trends (2017 to 2022) and forecast (2023 to 2028) by various segments and regions.
• Segmentation Analysis: Microbiome sequencing service market size by various segments, such as by technology, type, end use industry, and region in terms of value ($B).
• Regional Analysis: Microbiome sequencing service market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
• Growth Opportunities: Analysis of growth opportunities in different technologies, types, end use industries, and regions for the microbiome sequencing service market.
• Strategic Analysis: This includes M&A, new product development, and competitive landscape of the microbiome sequencing service market.
• Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

• Q.1. What is the microbiome sequencing service market size?
• Answer: The global microbiome sequencing service market is expected to reach an estimated $2.4 billion by 2028.
• Q.2. What is the growth forecast for microbiome sequencing service market?
• Answer: The global microbiome sequencing service market is expected to grow with a CAGR of 12.4% from 2023 to 2028
• Q.3. What are the major drivers influencing the growth of the microbiome sequencing service market?
• Answer: The major drivers for this market are increasing demand for metagenomic sequencing technology, high concentration on development of human microbiome therapeutics, as well as high costs associated with sophisticated sequencing instruments.
• Q4. What are the major segments for microbiome sequencing service market?
• Answer: The future of the global microbiome sequencing service market looks promising with opportunities in pharmaceutical and biotechnology companies and academic and research institutes.
• Q5. Who are the key microbiome sequencing service companies?
• Answer: Some of the key microbiome sequencing service companies are as follows:
  • Microbiome Insights
  • Baseclear
  • Clinical-Microbiomics
  • Merieux NutriSciences Corporation
  • MR DNA
  • Metabiomics
  • Rancho BioSciences
  • Second Genome
  • Zymo Research Corporation
  • uBiome
• Q6. Which microbiome sequencing service market segment will be the largest in future?
• Answer: Lucintel forecasts that sequencing by synthesis (SBS) will remain the highest growing segment over the forecast period due to its highly parallel structure that enables the simultaneous sequencing of millions of amplicons and increased interest in studying bacterial populations in the gut, skin, and other organs, each of which has a distinct microbial fingerprint. Moreover, it is an extensively used method by several commercial companies.
• Q7. In microbiome sequencing service market, which region is expected to be the largest in next 5 years?
• Answer: North America will remain the largest region over the forecast period due to well-developed research framework, cutting-edge technological progress, and the growing need for precision medicines in this region.
• Q.8. Do we receive customization in this report?
• Answer: Yes, Lucintel provides 10% Customization Without any Additional Cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the global microbiome sequencing service market by technology (sequencing by synthesis (SBS), sequencing by ligation (SBL), nanopore sequencing, sanger sequencing, and others), type (amplicon sequencing, whole-genome sequencing, shotgun sequencing, and others), end use industry (pharmaceutical and biotechnology companies, academic and research institutes, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last five years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Microbiome Sequencing Service Market: Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2017 to 2028

• 3.1: Macroeconomic Trends (2017-2022) and Forecast (2023-2028)
• 3.2: Global Microbiome Sequencing Service Market Trends (2017-2022) and Forecast (2023-2028)
• 3.3: Global Microbiome Sequencing Service Market by Technology
  • 3.3.1: Sequencing by Synthesis (SBS)
  • 3.3.2: Sequencing by Ligation (SBL)
  • 3.3.3: Nanopore Sequencing
  • 3.3.4: Sanger Sequencing
  • 3.3.5: Others
• 3.4: Global Microbiome Sequencing Service Market by Type
  • 3.4.1: Amplicon Sequencing
  • 3.4.2: Whole-Genome Sequencing
  • 3.4.3: Shotgun Sequencing
  • 3.4.4: Others
• 3.5: Global Microbiome Sequencing Service Market by End Use Industry
  • 3.5.1: Pharmaceutical and Biotechnology Companies
  • 3.5.2: Academic and Research Institutes
  • 3.5.3: Others

4. Market Trends and Forecast Analysis by Region from 2017 to 2028

• 4.1: Global Microbiome Sequencing Service Market by Region
• 4.2: North American Microbiome Sequencing Service Market
  • 4.2.1: North American Microbiome Sequencing Service Market by Technology: Sequencing by Synthesis (SBS), Sequencing by Ligation (SBL), and Nanopore Sequencing Sanger Sequencing
  • 4.2.2: North American Microbiome Sequencing Service Market by Type: Amplicon Sequencing, Whole-Genome Sequencing, Shotgun Sequencing, and Others
• 4.3: European Microbiome Sequencing Service Market
• 4.3: European Microbiome Sequencing Service Market
  • 4.3.1: European Microbiome Sequencing Service Market by Technology: Sequencing by Synthesis (SBS), Sequencing by Ligation (SBL), and Nanopore Sequencing Sanger Sequencing
  • 4.3.2: European Microbiome Sequencing Service Market by Type: Amplicon Sequencing, Whole-Genome Sequencing, Shotgun Sequencing, and Others
• 4.4: APAC Microbiome Sequencing Service Market
  • 4.4.1: APAC Microbiome Sequencing Service Market by Technology: Sequencing by Synthesis (SBS), Sequencing by Ligation (SBL), and Nanopore Sequencing Sanger Sequencing
  • 4.4.2: APAC Microbiome Sequencing Service Market by Type: Amplicon Sequencing, Whole-Genome Sequencing, Shotgun Sequencing, and Others
• 4.5: ROW Microbiome Sequencing Service Market
  • 4.5.1: ROW Microbiome Sequencing Service Market by Technology: Sequencing by Synthesis (SBS), Sequencing by Ligation (SBL), and Nanopore Sequencing Sanger Sequencing
  • 4.5.2: ROW Microbiome Sequencing Service Market by Type: Amplicon Sequencing, Whole-Genome Sequencing, Shotgun Sequencing, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Microbiome Sequencing Service Market by Technology
  • 6.1.2: Growth Opportunities for the Global Microbiome Sequencing Service Market by Type
  • 6.1.3: Growth Opportunities for the Global Microbiome Sequencing Service Market by End Use Industry
  • 6.1.4: Growth Opportunities for the Global Microbiome Sequencing Service Market by Region
• 6.2: Emerging Trends in the Global Microbiome Sequencing Service Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Microbiome Sequencing Service Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Microbiome Sequencing Service Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Microbiome Insights
• 7.2: Baseclear
• 7.3: Clinical-Microbiomics
• 7.4: Merieux NutriSciences Corporation
• 7.5: MR DNA
• 7.6: Metabiomics
• 7.7: Rancho BioSciences
• 7.8: Second Genome
• 7.9: Zymo Research Corporation
• 7.10: uBiome